Kangbaida

Beijing Kangbaida Pharmaceutical is a Chinese pharmaceutical company specializing in the development, production, and sale of chemical drug products. Founded in 2004 and headquartered in the Daxing Bio-medicine Industry Park in Beijing, the company focuses on therapeutic areas such as cardiovascular health, endocrinology, and gastroenterology. Its commercial portfolio includes widely prescribed generic medications, including amlodipine besylate for hypertension and gliclazide sustained-release tablets for diabetes. The company operates manufacturing facilities that meet national Good Manufacturing Practice (GMP) standards, ensuring the quality and safety of its oral solid dosage forms. Kangbaida aims to provide affordable and effective treatment options for chronic disease management within the Chinese healthcare market. Through its established distribution network, the company serves a broad range of hospitals and pharmacies across the country.